Drug intelligence / Profile preview

Bingzhi Shangtong

Development stage
Unknown
Lead developer
Guizhou Jingcheng Pharmaceutical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Topical
01

Overview

Bingzhi Shangtong is a botanical-based topical aerosol developed by Guizhou Antai Pharmaceutical Co., Ltd. for the treatment of acute closed soft tissue injuries, such as joint sprains. As a Traditional Chinese Medicine (TCM) formulation, it is designed to provide localized analgesic and anti-inflammatory effects when applied to the site of injury. The drug has undergone clinical evaluation in China, including a Phase 1/2 trial (CTR20150132) to assess its safety, pharmacokinetics, and therapeutic efficacy in both healthy volunteers and patients suffering from musculoskeletal trauma.

Brand names
Bingzhi Shangtong Aerosol
Other names
Bingzhi Shangtong Qiwuji冰止伤痛气雾剂
02

Targets

TRPV1 (Transient receptor potential cation channel subfamily V member 1)TRPM8 (Transient receptor potential cation channel subfamily M member 8)

Beyond the preview

Go deeper on Bingzhi Shangtong.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bingzhi Shangtong.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call